PERSPECTA

News from every angle

Back to headlines

INmune Bio, Inc. Q2 2026 Earnings Call Summary

A summary of the Q2 2026 earnings call for INmune Bio, Inc. has been released.

7 Aug, 04:37 — 7 Aug, 04:37
PostShare

Sources

Showing 1 of 1 sources